Microfluidics News and Research RSS Feed - Microfluidics News and Research

Epigem challenges students to come up with solutions to improve quality, safety of milk

Epigem, a high-tech British micro-engineering company, has challenged 15 students from the Durham University-led SOFI CDT (Centre for Doctoral Training in Soft Matter and Functional Interfaces), to come up with solutions to prevent a dangerous carcinogen from contaminating milk. [More]
Grand Challenges Canada announces $1.2 million in grant for 11 new global health innovations

Grand Challenges Canada announces $1.2 million in grant for 11 new global health innovations

Grand Challenges Canada, funded by the Government of Canada, today announced $1.2 million in funding for 11 new global health innovations implemented in member states of La Francophonie. [More]
OSU engineers identify method to prepare frozen red blood cells for transfusions

OSU engineers identify method to prepare frozen red blood cells for transfusions

Engineers at Oregon State University have identified a method to rapidly prepare frozen red blood cells for transfusions, which may offer an important new way to manage the world's blood supply. [More]
NIH announces high-risk, high-reward grants for UCSF researchers

NIH announces high-risk, high-reward grants for UCSF researchers

UC San Francisco researchers received five awards announced this week by the National Institutes of Health (NIH) for high-risk, high-reward scientific research projects. Their work will focus on novel approaches for diagnosing and treating diseases ranging from autoimmune and chronic inflammatory diseases, to cancer, diabetes and neurological disorders. [More]
Lung cancer can be detected much earlier using lab-on-a-chip technology

Lung cancer can be detected much earlier using lab-on-a-chip technology

Scientists have been laboring to detect cancer and a host of other diseases in people using promising new biomarkers called "exosomes." Indeed, Popular Science magazine named exosome-based cancer diagnostics one of the 20 breakthroughs that will shape the world this year. Exosomes could lead to less invasive, earlier detection of cancer, and sharply boost patients' odds of survival. [More]
UCSF researchers receive five NIH awards for high-risk scientific research projects

UCSF researchers receive five NIH awards for high-risk scientific research projects

UC San Francisco researchers received five awards announced this week by the National Institutes of Health for high-risk, high-reward scientific research projects. Their work will focus on novel approaches for diagnosing and treating diseases ranging from autoimmune and chronic inflammatory diseases, to cancer, diabetes and neurological disorders. [More]
Daktari receives NIH SBIR grant to develop point-of-care sickle cell diagnostic test

Daktari receives NIH SBIR grant to develop point-of-care sickle cell diagnostic test

Daktari Diagnostics, in collaboration with Harvard University, the Medical University of South Carolina, and the University of Zambia in Lusaka, is thrilled to announce that it has been awarded a Small Business Innovation Research grant by the National Institute of Health for a point-of-care sickle cell diagnostic test. [More]
Prominent scientists to deliver scientific presentations at ACS meeting

Prominent scientists to deliver scientific presentations at ACS meeting

The Kavli Foundation Lecture series today features two prominent scientists: one in the booming area of ionic liquids, the other in medical materials. [More]
OSU creates new assay to test authenticity of primary drugs used to treat malaria

OSU creates new assay to test authenticity of primary drugs used to treat malaria

Chemists and students in science and engineering at Oregon State University have created a new type of chemical test, or assay, that's inexpensive, simple, and can tell whether or not one of the primary drugs being used to treat malaria is genuine - an enormous and deadly problem in the developing world. [More]
Plasmonic biosensors: A key asset in personalised medicine

Plasmonic biosensors: A key asset in personalised medicine

A new type of high-sensitivity and low-cost sensors, called plasmonic biosensors, could ultimately become a key asset in personalised medicine by helping to diagnose diseases at an early stage. [More]

Double Emulsion System released by Dolomite

Microfluidic products expert Dolomite have released their Double Emulsion System for creating micron sized emulsion droplets that contain still smaller droplets inside. It enables unrivalled reproducibility and selectivity of droplet size of both outer and inner phases with either oil-in-water-in-oil or water-in-oil-in-water droplets. The Double Emulsion System is highly beneficial to applications in the food industry, in pharmaceuticals and cosmetics that use double emulsions as delivery vehicles or encapsulation solutions for various active ingredients, or more generally in paints and coatings. [More]

3D capillary device can increase production of high-quality liposomes

When the English author Sir Francis Bacon wrote "The world's a bubble" in 1629, it's a safe bet he wasn't thinking about microfluidics. [More]
The future of high throughput screening: an interview with Mark Wigglesworth, Director High Throughput Screening, AstraZeneca

The future of high throughput screening: an interview with Mark Wigglesworth, Director High Throughput Screening, AstraZeneca

Quoting Mike Snowden (VP & Head of Discovery Sciences, AstraZeneca), “it’s where biology meets chemistry”. It’s where for the first time a target protein can be probed for novel molecules that modulate its function, of course we want to do this to prove a hypothesis that these proteins are drug targets with the potential to deliver innovative medicines. [More]

Dolomite Microfluidics and Sphere Fluidics partner to deliver world leading droplet based technology

Sphere Fluidics and The Dolomite Centre Ltd. have now signed an exclusive distributor agreement for Sphere Fluidics' trademarked range of unique biochips, surfactants and other specialist chemicals for picodroplet applications. These will be promoted and sold via Dolomite’s worldwide sales channels. [More]
Biomedical engineer develops highly innovative technology to make blood transfusions safer

Biomedical engineer develops highly innovative technology to make blood transfusions safer

A biomedical engineer at the University of Houston (UH) is working to develop highly innovative technology to make blood transfusions safer. His work is supported by a $1.8 million grant from the National Institutes of Health (NIH). [More]
Sandia develops credit-card-sized anthrax detection cartridge to small business makes

Sandia develops credit-card-sized anthrax detection cartridge to small business makes

A credit-card-sized anthrax detection cartridge developed at Sandia National Laboratories and recently licensed to a small business makes testing safer, easier, faster and cheaper. [More]
Engineers develop tools to efficiently analyze living cells

Engineers develop tools to efficiently analyze living cells

For more than a decade Chang Lu, associate professor of chemical engineering at Virginia Tech, has worked on the development of tools to efficiently analyze living cells. The long-term goal is to gain a better understanding of a range of diseases. [More]

Ingenious droplet-on-demand system launched by Dolomite

Microfluidic products expert Dolomite has launched Mitos Dropix, an ingenious droplet-on-demand system capable of easily generating extremely miniaturised droplet compartments with exceptional control over volume, environment and isolation of contents. Meeting the increasing demand for screening massive numbers of biological reactions, increased speed of screening and reduced reagent consumption, Mitos Dropix technology now introduces liquid sampling and processing over a very wide 10 nL – 50 μL volume range utilizing droplet technology. [More]

GIN and Sigolis merge to create new company, Ginolis Oy

Global Innovation Network Oy (GIN) and Sigolis AB today announced a merger of the two companies. The new company, named Ginolis Oy, provides an innovative one-stop solution for the development and manufacturing of in vitro diagnostic (IVD) disposable products. [More]
New tool may hold key to personalized medicine applications in the future

New tool may hold key to personalized medicine applications in the future

ather than your average bowl of Lucky Charms, these are three-dimensional cell cultures generated by an exciting new digital microfluidics platform, the results of which have been published in Nature Communications this week by researchers at the University of Toronto. [More]